Children's Hospital Colorado
Peter Mourani, MD
Critical Care

Peter Mourani, MD

Medical Director, Children's Hospital Colorado Research Institute
Director, Clinical Research

Specialties:
Pediatrics, Pulmonology - Pediatric, Critical Care - Pediatric
Conditions:
Pulmonary Hypertension, Chronic Lung Disease of Prematurity (Bronchopulmonary Dysplasia)
specialties:

Pediatrics, Pulmonology - Pediatric, Critical Care - Pediatric

conditions:

Pulmonary Hypertension, Chronic Lung Disease of Prematurity (Bronchopulmonary Dysplasia)

Get to know his background

My clinical interests include management of acute and chronic lung disease in children, especially chronic lung disease of prematurity, as well as the management of pulmonary hypertension.

Undergraduate 1990

University of Notre Dame (IN)

Medical School 1994

Loyola University Chicago Stritch School of Medicine

Internship 1995

Loyola University Program

Residency 1997

Loyola University Program, Pediatrics

Fellowship 2001

University of Colorado (Children's Hospital Colorado) Program, Pediatric Pulmonology

Fellowship 2001

University of Colorado (Children's Hospital Colorado) Program, Pediatric Critical Care Medicine

Denver Top Doctor 2009

5280 Magazine

Denver Top Doctor 2010

5280 Magazine

Denver Top Doctor 2011

5280 Magazine

Denver Top Doctor 2012

5280 Magazine

Denver Top Doctor 2013

5280 Magazine

Denver Top Doctor 2014

5280 Magazine

Denver Top Doctor 2015

5280 Magazine

For Patients:
My research interests are primarily focused on investigating mechanisms of lung and lung blood vessel growth and injury in prematurely born infants. My research projects in this area explore prenatal and postnatal risk factors for impaired lung blood vessel growth and development of chronic lung disease, including pulmonary hypertension, in these infants. I am also investigating predictors of chronic lung disease and more sensitive measures to detect and measure disease severity. Additionally, I conduct NIH funded research projects utilizing molecular microbiome, transcriptomic, and proteomic analysis to investigate the contribution of different bacteria to ventilator associated pneumonia to facilitate improved prevention and treatment methods.
For Referring Providers:
My research interests are primarily focused on investigating mechanisms of lung and lung vascular development and injury in infants born preterm. My research projects in this area explore risk factors for impaired lung vascular development and chronic lung disease, including pulmonary hypertension, utilizing proteomic, airway microbiome, endothelial progenitor cells, and physiologic measures of lung disease. I also conduct NIH funded research projects utilizing molecular microbiome, transcriptomic, and proteomic analysis to investigate the mechanisms of ventilator associated pneumonia to facilitate improved prevention and treatment methodologies.

Medical Director, Children's Hospital Colorado Research Institute

Director, Clinical Research


PRODWEBSERVER1